Vimarsana
Biggest News Aggregation in the World

Accelerated Article Preview News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accelerated Article Preview. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accelerated Article Preview Today - Breaking & Trending Today

New Additive Improves Homogeneity of Perovskite Films for Solar Cells - Vimarsana News

New Additive Improves Homogeneity of Perovskite Films for Solar Cells

Scientists from the Hefei Institutes of Physical Science (HFIPS) at the Chinese Academy of Sciences have introduced a novel and highly promising approach for manufacturing uniform perovskite films for solar cells.

Source: azom.com
New AI algorithm helps achieve a 128-fold increase in COVID-19 vaccine's antibody response - Vimarsana News

New AI algorithm helps achieve a 128-fold increase in COVID-19 vaccine's antibody response

A team of researchers from Baidu Research has developed an AI algorithm that can rapidly design highly stable COVID-19 mRNA vaccine sequences that were previously unattainable.

Without Code for DeepMind's Protein AI, This Lab Wrote Its Own - Vimarsana News

Without Code for DeepMind's Protein AI, This Lab Wrote Its Own

The Google subsidiary solved a fundamental problem in biology but didn’t promptly share its solution. So a University of Washington team tried to re-create it.

Source: wired.com
TYK2 Identified as a Key Genetic Mechanism of Critical Illness in Covid-19 and as an Important Potential Target for Therapy - Vimarsana News

TYK2 Identified as a Key Genetic Mechanism of Critical Illness in Covid-19 and as an Important Potential Target for Therapy

Search jobs 14-Dec-2020 TYK2 Identified as a Key Genetic Mechanism of Critical Illness in Covid-19 and as an Important Potential Target for Therapy Findings published in Nature support scientific rationale for Sareum’s SDC-1801 development programme in Covid-19 and its recent grant award from UKRI Cambridge, UK, 14 December 2020 – Sareum Holdings plc (AIM: SAR), the specialist drug development company delivering targeted small molecule therapeutics to improve the treatment of cancer and autoimmune diseases, is pleased to note that a multi-cen...